Skip to content
healthcare.dev

Cyclobenzaprine Hydrochloride

NDC 65862-190, Cyclobenzaprine Hydrochloride, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
65862-190
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078643
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-190 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYCLOBENZAPRINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
65862-190-0165862019001100 TABLET, FILM COATED in 1 BOTTLE (65862-190-01)
65862-190-0565862019005500 TABLET, FILM COATED in 1 BOTTLE (65862-190-05)
65862-190-99658620190991000 TABLET, FILM COATED in 1 BOTTLE (65862-190-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1154688c-1383-442b-a3a5-ec01e038795c

Use it

Look up 65862-190 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-190 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-190. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.